Allied Corp. engages in the research, creation, and production of cannabinoid health solutions. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2018-12-04. The company is focused on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder, Parkinson's disease, Tourette's syndrome, irritable bowel syndrome and spasticity associated with multiple sclerosis and spinal cord injury. Its core hemp derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. Liberty, Tactical Relief brand's flagship product, is a hemp derived CBD tincture for sale in the United States. Equilibrium Bio brand is primarily focused on hydration and recovery areas. MaXXa brand develops natural CBD infused cosmetics and beauty products. Its subsidiaries include AM Biosciences, Allied US Products LLC, Tactical Relief LLC, Baleno Ltd. and Allied Colombia.
Follow-Up Questions
ALID 股票的價格表現如何？
ALID 的當前價格為 $0.0111，在上個交易日 decreased 了 0%。
Allied Corp 的主要業務主題或行業是什麼？
Allied Corp 屬於 Pharmaceuticals 行業，該板塊是 Health Care
